THE MINIMUM EFFECTIVE DOSE OF ESTROGEN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS
- 1 January 1984
- journal article
- research article
- Vol. 63 (6) , 759-763
Abstract
In a controlled single blind study to determine the minimal effective dose of estrogen for protection against bone loss, conjugated equine estrogens in doses of 0.625 and 1.25 mg per day were equally effective in reducing bone loss in postmenopausal and oophorectomized women when bone mass was estimated by single-photon absorptiometry or radiogrammetry. Daily dose levels of < 0.625 mg were essentially ineffective. Fifty percent response level was calculated to be 0.45 mg/day. Concomitant biochemical effects, reduction in urine calcium and hydroxyproline, were compatible with the observed effects on bone mineral.This publication has 8 references indexed in Scilit:
- PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMENThe Lancet, 1980
- Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1980
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- ESTROGEN REPLACEMENT THERAPY .1. 10-YEAR PROSPECTIVE-STUDY IN THE RELATIONSHIP TO OSTEOPOROSIS1979
- Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal WomenClinical Science, 1978
- Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal WomenAnnals of Internal Medicine, 1977
- Determination of hydroxyprolineClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- Measurement of Bone Mineral in vivo: An Improved MethodScience, 1963